<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">DICLOXACILLIN SODIUM</span><br/>(dye-klox-a-sill'in)<br/><span class="topboxtradename">Dycill, </span><span class="topboxtradename">Dynapen, </span><span class="topboxtradename">Pathocil<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">antibiotic</span>; <span class="classification">semisynthetic penicillin</span><br/><b>Prototype: </b>Penicillin G potassium<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>125 mg, 250 mg, 500 mg capsules; 62.5 mg/5 mL suspension</p>
<h1><a name="action">Actions</a></h1>
<p>Semisynthetic, acid-stable, penicillinase-resistant isoxazolyl penicillin. Action is bactericidal. Inhibits biosynthesis of
         bacterial cell wall during stage of active multiplication.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Reportedly the most active of the isoxazolyl penicillins (cloxacillin, oxacillin) against penicillinase-producing <i>Staphylococci</i>. Generally ineffective against methicillin-resistant <i>Staphylococci</i> and gram-negative bacteria.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Primarily in systemic infections caused by penicillinase-producing <i>Staphylococci</i> and penicillin-resistant <i>Staphylococci</i>.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to penicillins. Safe use during pregnancy (category B) or in neonates is not established.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>History of or suspected atopy or allergy (asthma, eczema, hives, hay fever); history of hypersensitivity to cephalosporins;
         lactation; renal or hepatic impairment.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Mild to Moderate Infections</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 125500 mg q6h<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span>
<i>, 12.525 mg/kg q6h (max: 4 g/d)<br/></i></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give on an empty stomach at least 1 h before or 2 h after meals. Food reduces drug absorption.</li>
<li>Reconstitute powder for oral suspension by shaking container to loosen powder. Add water according to label starting with
            half of the amount, then shake vigorously. Add remaining half and shake again vigorously. Shake well before each use.
         </li>
<li>Store reconstituted oral suspensions for 7 d at room temperature (15°30° C; 59°86° F) or 14
            d under refrigeration at 2°8° C (36°46° F). Date and label container. Store capsules at room
            temperature in tight containers unless otherwise directed.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Hypersensitivity (pruritus, urticaria, rash, wheezing, sneezing, <span class="speceff-life">anaphylaxis</span>; eosinophilia). <span class="typehead">GI:</span> Nausea, vomiting, flatulence, <span class="speceff-common">diarrhea,</span> abdominal pain. <span class="typehead">Other:</span> Transient elevations of ALT, superinfections. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Probenecid</b> decreases dicloxacillin elimination. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> 3576% absorbed from GI tract. <span class="typehead">Peak:</span> 0.52 h. <span class="typehead">Duration:</span> 46 h. <span class="typehead">Distribution:</span> Distributed throughout body with highest concentrations in liver and kidney; low CSF penetration; crosses placenta; distributed
      into breast milk. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Excreted primarily in urine with some elimination through bile. <span class="typehead">Half-Life:</span> 3060 min. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>
            							Note: Take care to establish previous exposure and sensitivity to penicillins and cephalosporins as well as other allergic reactions
            of any kind before initiating therapy.
            						
         </li>
<li>Obtain C&amp;S prior to initiation of therapy to determine susceptibility of causative organism. Therapy may begin pending test
            results.
         </li>
<li>Lab tests: Baseline blood cultures, WBC, and differential counts and at least weekly for patients on prolonged therapy. Periodic
            ALT and AST determinations, urinalysis, BUN, and creatinine are also advised for these patients.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Take medication around the clock. Do not miss a dose and continue taking medication until it is all gone, unless otherwise
            directed by physician.
         </li>
<li>Check with physician if GI side effects appear.</li>
<li>Watch for and report the signs of hypersensitivity reactions and superinfections (see Appendix F).</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>